Lanean...
Minimum target prices for production of direct-acting antivirals and associated diagnostics to combat hepatitis C virus
Combinations of direct-acting antivirals (DAAs) can cure hepatitis C virus (HCV) in the majority of treatment-naïve patients. Mass treatment programs to cure HCV in developing countries are only feasible if the costs of treatment and laboratory diagnostics are very low. This analysis aimed to estima...
Gorde:
| Argitaratua izan da: | Hepatology |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BlackWell Publishing Ltd
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4403972/ https://ncbi.nlm.nih.gov/pubmed/25482139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.27641 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|